Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- Rezolve Ai PLC (NASDAQ: RZLV), a leader in AI-powered commerce infrastructure, today issued a direct response to the Commerce.com Board of Directors. On...
-
Calroy publishes new research explaining how marine-derived rhamnan sulfate may support the endothelial glycocalyx and vascular circulation.
-
RENO, Nev., April 09, 2026 (GLOBE NEWSWIRE) -- ITS Logistics, now an Echo Global Logistics company, is doubling down on the fraud mitigation strategy that has produced a critical incident rate of...
-
Austin, TX, April 09, 2026 (GLOBE NEWSWIRE) -- Wetour Robotics Limited (NASDAQ: WETO) ("Wetour Robotics" or the "Company"), a Physical AI infrastructure and wearable robotics company headquartered...
-
LOS ANGELES, April 09, 2026 (GLOBE NEWSWIRE) -- urVETTED, the gold standard in culture and inclusion validation, today announced its launch, introducing a new category of cultural intelligence to...
-
STUDIO CITY, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- As this year’s Myeloma Action Month came to a close, the International Myeloma Foundation (IMF) was truly grateful for the incredible support...
-
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- Fairmint, a pioneer in onchain equity infrastructure, announced today the acquisition of The RWA Desk, a New York City private events and media platform...
-
Vinci Enables Realbotix Robots to Recognize People, Recall Conversations, and Track Engagement; Onconetix Recently Entered into a Definitive Agreement to Acquire Realbotix LLC, a Subsidiary of...
-
Dublin, April 09, 2026 (GLOBE NEWSWIRE) -- The "Semiconductor Intellectual Property Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The...
-
Publication strengthens NetraMark's case for biomarker-guided enrichment, individualized response modeling, and explainable AI for trial design in psychedelic clinical development. TORONTO, April ...